eaa777cd_CER_Inventory___CER_Inventory__Category
[Agency] NIH [Project Title] EFFECTIVENESS OF EARLY STAGE PROSTATE CANCER TREATMENT [Institution] BETH ISRAEL DEACONESS MEDICAL CENTER [Amount] $499,994 [Summary] Aim 1. To generate and validate models that use pre-treatment HRQOL, clinical status, and treatment details to predict HRQOL changes after each of the three most common primary treatments for early stage prostate cancer: prostatectomy, external radiotherapy, or brachytherapy Aim 2. To construct decision analytic Markov models to predict QALE of primary prostate cancer treatments using prospective cohort data to drive transition probabilities between HRQOL states. Aim 3. To characterize treatment-related costs and combine these with QALE in the Markov model framework to assess overall cost effectiveness as measured by incremental cost-effectiveness ratio (ICER), of prostatectomy, external radiotherapy, or brachytherapy for early stage prostate cancer. [Completion/ Closing Date] 09/02/2010 [Link] link [Category] 
Medical treatments, items and services
CER Inventory | CER Inventory
Category